TY - JOUR
T1 - Elevated lung clearance index in infants with cystic fibrosis shortly after birth
AU - SCILD and BILD study groups
AU - Kieninger, Elisabeth
AU - Yammine, Sophie
AU - Korten, Insa
AU - Anagnostopoulou, Pinelopi
AU - Singer, Florian
AU - Frey, Urs
AU - Mornand, Anne
AU - Zanolari, Maura
AU - Rochat, Isabelle
AU - Trachsel, Daniel
AU - Mueller-Suter, Dominik
AU - Moeller, Alexander
AU - Casaulta, Carmen
AU - Latzin, Philipp
AU - Barben, Juerg
AU - Hafen, Gaudenz
AU - Regamey, Nicolas
AU - Kentgens, Anne Christianne
AU - Egger, Barbara
AU - Fuchs, Oliver
AU - Kuehni, Claudia
AU - Proietti, Elena
AU - Schmidt, Anne
AU - Usemann, Jakob
N1 - Funding Information:
Support statement: The work for this report was funded by the Swiss Society for Cystic Fibrosis (CFCH), the Gottfried und Julia Bangerter-Rhyner-Stiftung, the Fondazione Ettore e Valeria Rossi, the Swiss National Science Foundation (grant 144280 and 163311 to U. Frey, P. Latzin and C. Kuehni) and the Botnar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding information for this article has been deposited with the Crossref Funder Registry.
Publisher Copyright:
© Copyright ERS 2017.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF). We assessed lung function shortly after birth in infants with CF diagnosed by newborn screening. We performed infant lung function measurements in a prospective cohort of infants with CF and healthy controls. We assessed lung clearance index (LCI), functional residual capacity (FRC) and tidal breathing parameters. The primary outcome was prevalence and severity of abnormal lung function (±1.64 z-scores) in CF. We enrolled 53 infants with CF (mean age 7.8 weeks) and 57 controls (mean age 5.2 weeks). Compared to controls, LCI and FRC were elevated (mean difference 0.30, 95% CI 0.02-0.60; p=0.034 and 14.5 mL, 95% CI 7.7-21.3 mL; p<0.001, respectively), while ratio of time to peak tidal expiratory flow to expiratory time was decreased in infants with CF. In 22 (41.5%) infants with CF, either LCI or FRC exceeded 1.64 z-scores; three infants had both elevated LCI and FRC. Shortly after birth, abnormal lung function is prevalent in CF infants. Ventilation inhomogeneity or hyperinflation may serve as noninvasive markers to monitor CF lung disease and specific treatment effects, and could thus be used as outcome parameters for future intervention studies in this age group.
AB - It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF). We assessed lung function shortly after birth in infants with CF diagnosed by newborn screening. We performed infant lung function measurements in a prospective cohort of infants with CF and healthy controls. We assessed lung clearance index (LCI), functional residual capacity (FRC) and tidal breathing parameters. The primary outcome was prevalence and severity of abnormal lung function (±1.64 z-scores) in CF. We enrolled 53 infants with CF (mean age 7.8 weeks) and 57 controls (mean age 5.2 weeks). Compared to controls, LCI and FRC were elevated (mean difference 0.30, 95% CI 0.02-0.60; p=0.034 and 14.5 mL, 95% CI 7.7-21.3 mL; p<0.001, respectively), while ratio of time to peak tidal expiratory flow to expiratory time was decreased in infants with CF. In 22 (41.5%) infants with CF, either LCI or FRC exceeded 1.64 z-scores; three infants had both elevated LCI and FRC. Shortly after birth, abnormal lung function is prevalent in CF infants. Ventilation inhomogeneity or hyperinflation may serve as noninvasive markers to monitor CF lung disease and specific treatment effects, and could thus be used as outcome parameters for future intervention studies in this age group.
UR - http://www.scopus.com/inward/record.url?scp=85034989685&partnerID=8YFLogxK
U2 - 10.1183/13993003.00580-2017
DO - 10.1183/13993003.00580-2017
M3 - Journal articles
C2 - 29122915
AN - SCOPUS:85034989685
SN - 0903-1936
VL - 50
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 5
M1 - 1700580
ER -